These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3053206)

  • 1. Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay.
    Schroyens WA; Meeker JB; Dodion P; Stryckmans PA; Rozencweig M
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1309-12. PubMed ID: 3053206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mutagenic and carcinogenic properties of three second generation antitumour platinum compounds: a comparison with cisplatin.
    Chibber R; Ord MJ
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):27-33. PubMed ID: 2646132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
    Prajda N; Kralovánszky J; Gal F; Kiss F; Kerpel-Fronius S
    In Vivo; 1989; 3(4):267-70. PubMed ID: 2519864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.
    Dodion P; Sanders C; Georges P; Kenis Y
    Cancer Chemother Pharmacol; 1988; 22(1):80-2. PubMed ID: 3293841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS; Fanta PT; Running KL; Adair LP; Garcia DJ; Liu-Stevens R; Salmon SE
    Cancer Chemother Pharmacol; 1997; 39(6):493-7. PubMed ID: 9118460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming reduces the bone marrow toxicity of carboplatin.
    Gore ME; Hills CA; Siddik ZH; Sloane JP; Winkley AR; Smith IE; Millar JL
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):75-80. PubMed ID: 3297714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ; Kelland LR; Harrap KR
    Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
    van Rongen E; Kal HB; Kuijpers WC; van Berkel AH
    Strahlenther Onkol; 1992 May; 168(5):300-7. PubMed ID: 1598667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin.
    Skov K; MacPhail S
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):221-5. PubMed ID: 1991682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of platinol analogs using the M5076 murine sarcoma.
    Rose WC
    Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect.
    Su WC; Chang SL; Chen TY; Chen JS; Tsao CJ
    Jpn J Clin Oncol; 2000 Dec; 30(12):562-7. PubMed ID: 11210167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the nephrotoxicity of iproplatin (CHIP) in comparison to cisplatin by the measurement of urinary enzymes.
    Pendyala L; Madajewicz S; Lele SB; Arbuck SG; Creaven PJ
    Cancer Chemother Pharmacol; 1985; 15(3):203-7. PubMed ID: 4053265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR.
    Viale M; Minetti S; Ottone M; Lerza R; Parodi B; Pannacciulli I
    Anticancer Drugs; 2003 Feb; 14(2):163-6. PubMed ID: 12569303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II).
    Gringeri A; Keng PC; Borch RF
    Cancer Res; 1988 Oct; 48(20):5708-12. PubMed ID: 2844391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
    Gulati SC; Atzpodien J; Langleben A; Shimazaki C; Jain K; Yopp J; Ng RP; Colvin OM; Clarkson BD
    Acta Haematol; 1988; 80(2):65-70. PubMed ID: 2458665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.